+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microarray Market By Product & Services, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 255 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5713125
The global microarray market was valued at $3,947.18 million in 2021, and is projected to reach $8,399.97 million by 2031, registering a CAGR of 7.8% from 2022 to 2031.

The microarray is a laboratory tool used to detect the expression of thousands of genes at the same time. DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. DNA microarrays are used in clinical diagnostic tests for some diseases. Sometimes they are also used to determine which drugs might be best prescribed for particular individuals, because genes determine how our bodies handle the chemistry related to those drugs. With the advent of new DNA sequencing technologies, some of the tests for which microarrays were used in the past now use DNA sequencing instead. But microarray tests still tend to be less expensive than sequencing, so they may be used for very large studies, as well as for some clinical tests. The principle behind microarrays is that the unknown DNA molecules are cut into fragments by restriction endonucleases; fluorescent markers are attached to these DNA fragments. These are then allowed to react with probes of the DNA chip. Then the target DNA fragments along with complementary sequences bind to the DNA probes. The remaining DNA fragments are washed away. The target DNA pieces can be identified by their fluorescence emission by passing a laser beam. A computer is used to record the pattern of fluorescence emission and DNA identification. This technique of employing DNA chips is very rapid, besides being sensitive and specific for the identification of several DNA fragments simultaneously.

The global microarray market is anticipated to show significant market growth during the forecast period, owing to increase in number of on-going R&D activities, increase in government support for research and development activities and increase in healthcare expenditure. Furthermore, rise in the incidence of cancer, the rapidly evolving information and software technology and emerging bioinformatics are considerably contributing toward the market growth. However, limitations of microarray analysis technology and lack of skilled professionals are negatively impacting the market growth. Conversely, the surge in applications of microarray technique in medical field offers the lucrative opportunities for the growth of the market.

The global microarray market is segmented on the basis of product & services, type, end user and region. Based on product & services, the market is classified into consumable, instruments, software and services. Furthermore, the consumable segment is sub-classified as research applications, drug discovery, disease diagnostics and other applications. Also, the instruments segment is sub-classified as research applications, drug discovery, disease diagnostics and other applications. The software and services segment is sub-classified as research applications, drug discovery, disease diagnostics and other applications. By type, the market is classified into DNA microarray, protein microarray, and other microarray. By end user, the market is classified into research and academic institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, other end users. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

The major companies profiled in the report include Agilent Technologies, Inc., Arrayit Corporation, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation (Molecular Devices), Diasorin Group (Luminex Corporation), GE company (GE Healthcare), Illumina, Inc., Invitae Corporation, Merck KGaA, Microarray Inc., NextGen Sciences, PathogenDx, Inc., PerkinElmer Inc., RayBiotech Life, Inc., Schott Minifab (Applied Microarrays), Thermo Fisher Scientific, Inc (Affymetrix, Inc.).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microarray market analysis from 2021 to 2031 to identify the prevailing microarray market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the microarray market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global microarray market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Services

  • Consumable
  • Application
  • Research Applications
  • Drug Discovery
  • Disease Diagnostics
  • Other Applications
  • Instruments
  • Application
  • Research Applications
  • Drug Discovery
  • Disease Diagnostics
  • Other Applications
  • Software and Services
  • Application
  • Research Applications
  • Drug Discovery
  • Disease Diagnostics
  • Other Applications

By Type

  • DNA Microarray
  • Protein Microarray
  • Other Microarray

By End User

  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest Of Asia-Pacific
  • LAMEA
  • Saudi Arabia
  • South Arabia
  • Rest Of LAMEA
  • Brazil

Key Market Players

  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Diasorin Group
  • GE Healthcare
  • Illumina, Inc.
  • Invitae Corporation
  • Merck KGaA
  • Microarray Inc.
  • NextGen Sciences
  • PathogenDx, Inc.
  • PerkinElmer Inc.
  • RayBiotech Life, Inc.
  • Schott Minifab
  • Thermo Fisher Scientific, Inc
Frequently Asked Questions about the Global Microarray Market

What is the estimated value of the Global Microarray Market?

The Global Microarray Market was estimated to be valued at $3947.18 million in 2021.

What is the growth rate of the Global Microarray Market?

The growth rate of the Global Microarray Market is 7.8%, with an estimated value of $8399.97 million by 2031.

What is the forecasted size of the Global Microarray Market?

The Global Microarray Market is estimated to be worth $8399.97 million by 2031.

Who are the key companies in the Global Microarray Market?

Key companies in the Global Microarray Market include Agilent Technologies, Inc., Arrayit Corporation, bioMérieux SA, Bio, Rad Laboratories Inc., Danaher Corporation, Diasorin Group, GE Healthcare and Invitae Corporation.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: MICROARRAY MARKET, BY PRODUCT & SERVICES
4.1 Overview
4.1.1 Market size and forecast
4.2 Consumable
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Consumable Microarray Market by Application
4.2.4.1 Research Applications Market size and forecast, by region
4.2.4.2 Drug Discovery Market size and forecast, by region
4.2.4.3 Disease Diagnostics Market size and forecast, by region
4.2.4.4 Other Applications Market size and forecast, by region
4.3 Instruments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Instruments Microarray Market by Application
4.3.4.1 Research Applications Market size and forecast, by region
4.3.4.2 Drug Discovery Market size and forecast, by region
4.3.4.3 Disease Diagnostics Market size and forecast, by region
4.3.4.4 Other Applications Market size and forecast, by region
4.4 Software and Services
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.4.4 Software and Services Microarray Market by Application
4.4.4.1 Research Applications Market size and forecast, by region
4.4.4.2 Drug Discovery Market size and forecast, by region
4.4.4.3 Disease Diagnostics Market size and forecast, by region
4.4.4.4 Other Applications Market size and forecast, by region

CHAPTER 5: MICROARRAY MARKET, BY BY TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 DNA Microarray
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Protein Microarray
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Other Microarray
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country

CHAPTER 6: MICROARRAY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Research and Academic Institutes
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Pharmaceutical and Biotechnology Companies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Diagnostic Laboratories
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Other End Users
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country

CHAPTER 7: MICROARRAY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product & Services
7.2.2.1 North America Consumable Microarray Market by Application
7.2.2.2 North America Instruments Microarray Market by Application
7.2.2.3 North America Software and Services Microarray Market by Application
7.2.3 North America Market size and forecast, by By Type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product & Services
7.2.5.1.2 Market size and forecast, by By Type
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product & Services
7.2.5.2.2 Market size and forecast, by By Type
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product & Services
7.2.5.3.2 Market size and forecast, by By Type
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product & Services
7.3.2.1 Europe Consumable Microarray Market by Application
7.3.2.2 Europe Instruments Microarray Market by Application
7.3.2.3 Europe Software and Services Microarray Market by Application
7.3.3 Europe Market size and forecast, by By Type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product & Services
7.3.5.1.2 Market size and forecast, by By Type
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product & Services
7.3.5.2.2 Market size and forecast, by By Type
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product & Services
7.3.5.3.2 Market size and forecast, by By Type
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product & Services
7.3.5.4.2 Market size and forecast, by By Type
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product & Services
7.3.5.5.2 Market size and forecast, by By Type
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product & Services
7.3.5.6.2 Market size and forecast, by By Type
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product & Services
7.4.2.1 Asia-Pacific Consumable Microarray Market by Application
7.4.2.2 Asia-Pacific Instruments Microarray Market by Application
7.4.2.3 Asia-Pacific Software and Services Microarray Market by Application
7.4.3 Asia-Pacific Market size and forecast, by By Type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product & Services
7.4.5.1.2 Market size and forecast, by By Type
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product & Services
7.4.5.2.2 Market size and forecast, by By Type
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product & Services
7.4.5.3.2 Market size and forecast, by By Type
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product & Services
7.4.5.4.2 Market size and forecast, by By Type
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product & Services
7.4.5.5.2 Market size and forecast, by By Type
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product & Services
7.4.5.6.2 Market size and forecast, by By Type
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product & Services
7.5.2.1 LAMEA Consumable Microarray Market by Application
7.5.2.2 LAMEA Instruments Microarray Market by Application
7.5.2.3 LAMEA Software and Services Microarray Market by Application
7.5.3 LAMEA Market size and forecast, by By Type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product & Services
7.5.5.1.2 Market size and forecast, by By Type
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product & Services
7.5.5.2.2 Market size and forecast, by By Type
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Arabia
7.5.5.3.1 Market size and forecast, by Product & Services
7.5.5.3.2 Market size and forecast, by By Type
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product & Services
7.5.5.4.2 Market size and forecast, by By Type
7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Agilent Technologies, Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Arrayit Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 bioMérieU.S.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Bio-Rad Laboratories Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Danaher Corporation
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Diasorin Group
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 GE Healthcare
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Illumina, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Invitae Corporation
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Merck KGaA
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Microarray Inc.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 NextGen Sciences
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 PathogenDx, Inc.
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 PerkinElmer Inc.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 RayBiotech Life, Inc.
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 Schott Minifab
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Thermo Fisher Scientific, Inc
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments

List of Tables
Table 1. Global Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 2. Microarray Market, for Consumable, by Region, 2021-2031 ($Million)
Table 3. Microarray Market for Consumable, by Country, 2021-2031 ($Million)
Table 4. Global Consumable Microarray Market, by Application, 2021-2031 ($Million)
Table 5. Microarray Market, for Research Applications, by Region, 2021-2031 ($Million)
Table 6. Microarray Market, for Drug Discovery, by Region, 2021-2031 ($Million)
Table 7. Microarray Market, for Disease Diagnostics, by Region, 2021-2031 ($Million)
Table 8. Microarray Market, for Other Applications, by Region, 2021-2031 ($Million)
Table 9. Microarray Market, for Instruments, by Region, 2021-2031 ($Million)
Table 10. Microarray Market for Instruments, by Country, 2021-2031 ($Million)
Table 11. Global Instruments Microarray Market, by Application, 2021-2031 ($Million)
Table 12. Microarray Market, for Research Applications, by Region, 2021-2031 ($Million)
Table 13. Microarray Market, for Drug Discovery, by Region, 2021-2031 ($Million)
Table 14. Microarray Market, for Disease Diagnostics, by Region, 2021-2031 ($Million)
Table 15. Microarray Market, for Other Applications, by Region, 2021-2031 ($Million)
Table 16. Microarray Market, for Software and Services, by Region, 2021-2031 ($Million)
Table 17. Microarray Market for Software and Services, by Country, 2021-2031 ($Million)
Table 18. Global Software and Services Microarray Market, by Application, 2021-2031 ($Million)
Table 19. Microarray Market, for Research Applications, by Region, 2021-2031 ($Million)
Table 20. Microarray Market, for Drug Discovery, by Region, 2021-2031 ($Million)
Table 21. Microarray Market, for Disease Diagnostics, by Region, 2021-2031 ($Million)
Table 22. Microarray Market, for Other Applications, by Region, 2021-2031 ($Million)
Table 23. Global Microarray Market, by By Type, 2021-2031 ($Million)
Table 24. Microarray Market, for DNA Microarray, by Region, 2021-2031 ($Million)
Table 25. Microarray Market for DNA Microarray, by Country, 2021-2031 ($Million)
Table 26. Microarray Market, for Protein Microarray, by Region, 2021-2031 ($Million)
Table 27. Microarray Market for Protein Microarray, by Country, 2021-2031 ($Million)
Table 28. Microarray Market, for Other Microarray, by Region, 2021-2031 ($Million)
Table 29. Microarray Market for Other Microarray, by Country, 2021-2031 ($Million)
Table 30. Global Microarray Market, by End-user, 2021-2031 ($Million)
Table 31. Microarray Market, for Research and Academic Institutes, by Region, 2021-2031 ($Million)
Table 32. Microarray Market for Research and Academic Institutes, by Country, 2021-2031 ($Million)
Table 33. Microarray Market, for Pharmaceutical and Biotechnology Companies, by Region, 2021-2031 ($Million)
Table 34. Microarray Market for Pharmaceutical and Biotechnology Companies, by Country, 2021-2031 ($Million)
Table 35. Microarray Market, for Diagnostic Laboratories, by Region, 2021-2031 ($Million)
Table 36. Microarray Market for Diagnostic Laboratories, by Country, 2021-2031 ($Million)
Table 37. Microarray Market, for Other End-users, by Region, 2021-2031 ($Million)
Table 38. Microarray Market for Other End-users, by Country, 2021-2031 ($Million)
Table 39. Microarray Market, by Region, 2021-2031 ($Million)
Table 40. North America Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 41. North America Consumable Microarray Market, by Application, 2021-2031 ($Million)
Table 42. North America Instruments Microarray Market, by Application, 2021-2031 ($Million)
Table 43. North America Software and Services Microarray Market, by Application, 2021-2031 ($Million)
Table 44. North America Microarray Market, by By Type, 2021-2031 ($Million)
Table 45. North America Microarray Market, by End-user, 2021-2031 ($Million)
Table 46. North America Microarray Market, by Country, 2021-2031 ($Million)
Table 47. U.S. Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 48. U.S. Microarray Market, by By Type, 2021-2031 ($Million)
Table 49. U.S. Microarray Market, by End-user, 2021-2031 ($Million)
Table 50. Canada Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 51. Canada Microarray Market, by By Type, 2021-2031 ($Million)
Table 52. Canada Microarray Market, by End-user, 2021-2031 ($Million)
Table 53. Mexico Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 54. Mexico Microarray Market, by By Type, 2021-2031 ($Million)
Table 55. Mexico Microarray Market, by End-user, 2021-2031 ($Million)
Table 56. Europe Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 57. Europe Consumable Microarray Market, by Application, 2021-2031 ($Million)
Table 58. Europe Instruments Microarray Market, by Application, 2021-2031 ($Million)
Table 59. Europe Software and Services Microarray Market, by Application, 2021-2031 ($Million)
Table 60. Europe Microarray Market, by By Type, 2021-2031 ($Million)
Table 61. Europe Microarray Market, by End-user, 2021-2031 ($Million)
Table 62. Europe Microarray Market, by Country, 2021-2031 ($Million)
Table 63. Germany Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 64. Germany Microarray Market, by By Type, 2021-2031 ($Million)
Table 65. Germany Microarray Market, by End-user, 2021-2031 ($Million)
Table 66. France Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 67. France Microarray Market, by By Type, 2021-2031 ($Million)
Table 68. France Microarray Market, by End-user, 2021-2031 ($Million)
Table 69. UK Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 70. UK Microarray Market, by By Type, 2021-2031 ($Million)
Table 71. UK Microarray Market, by End-user, 2021-2031 ($Million)
Table 72. Italy Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 73. Italy Microarray Market, by By Type, 2021-2031 ($Million)
Table 74. Italy Microarray Market, by End-user, 2021-2031 ($Million)
Table 75. Spain Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 76. Spain Microarray Market, by By Type, 2021-2031 ($Million)
Table 77. Spain Microarray Market, by End-user, 2021-2031 ($Million)
Table 78. Rest of Europe Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 79. Rest of Europe Microarray Market, by By Type, 2021-2031 ($Million)
Table 80. Rest of Europe Microarray Market, by End-user, 2021-2031 ($Million)
Table 81. Asia-Pacific Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 82. Asia-Pacific Consumable Microarray Market, by Application, 2021-2031 ($Million)
Table 83. Asia-Pacific Instruments Microarray Market, by Application, 2021-2031 ($Million)
Table 84. Asia-Pacific Software and Services Microarray Market, by Application, 2021-2031 ($Million)
Table 85. Asia-Pacific Microarray Market, by By Type, 2021-2031 ($Million)
Table 86. Asia-Pacific Microarray Market, by End-user, 2021-2031 ($Million)
Table 87. Asia-Pacific Microarray Market, by Country, 2021-2031 ($Million)
Table 88. China Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 89. China Microarray Market, by By Type, 2021-2031 ($Million)
Table 90. China Microarray Market, by End-user, 2021-2031 ($Million)
Table 91. Japan Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 92. Japan Microarray Market, by By Type, 2021-2031 ($Million)
Table 93. Japan Microarray Market, by End-user, 2021-2031 ($Million)
Table 94. India Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 95. India Microarray Market, by By Type, 2021-2031 ($Million)
Table 96. India Microarray Market, by End-user, 2021-2031 ($Million)
Table 97. Australia Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 98. Australia Microarray Market, by By Type, 2021-2031 ($Million)
Table 99. Australia Microarray Market, by End-user, 2021-2031 ($Million)
Table 100. South Korea Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 101. South Korea Microarray Market, by By Type, 2021-2031 ($Million)
Table 102. South Korea Microarray Market, by End-user, 2021-2031 ($Million)
Table 103. Rest of Asia-Pacific Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 104. Rest of Asia-Pacific Microarray Market, by By Type, 2021-2031 ($Million)
Table 105. Rest of Asia-Pacific Microarray Market, by End-user, 2021-2031 ($Million)
Table 106. LAMEA Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 107. LAMEA Consumable Microarray Market, by Application, 2021-2031 ($Million)
Table 108. LAMEA Instruments Microarray Market, by Application, 2021-2031 ($Million)
Table 109. LAMEA Software and Services Microarray Market, by Application, 2021-2031 ($Million)
Table 110. LAMEA Microarray Market, by By Type, 2021-2031 ($Million)
Table 111. LAMEA Microarray Market, by End-user, 2021-2031 ($Million)
Table 112. LAMEA Microarray Market, by Country, 2021-2031 ($Million)
Table 113. Brazil Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 114. Brazil Microarray Market, by By Type, 2021-2031 ($Million)
Table 115. Brazil Microarray Market, by End-user, 2021-2031 ($Million)
Table 116. Saudi Arabia Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 117. Saudi Arabia Microarray Market, by By Type, 2021-2031 ($Million)
Table 118. Saudi Arabia Microarray Market, by End-user, 2021-2031 ($Million)
Table 119. South Arabia Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 120. South Arabia Microarray Market, by By Type, 2021-2031 ($Million)
Table 121. South Arabia Microarray Market, by End-user, 2021-2031 ($Million)
Table 122. Rest of LAMEA Microarray Market, by Product & Services, 2021-2031 ($Million)
Table 123. Rest of LAMEA Microarray Market, by By Type, 2021-2031 ($Million)
Table 124. Rest of LAMEA Microarray Market, by End-user, 2021-2031 ($Million)
Table 125. Agilent Technologies, Inc.: Company Snapshot
Table 126. Agilent Technologies, Inc.: Operating Segments
Table 127. Agilent Technologies, Inc.: Product Portfolio
Table 128. Agilent Technologies, Inc.: Net Sales
Table 129. Agilent Technologies, Inc.: Key Strategies
Table 130. Arrayit Corporation: Company Snapshot
Table 131. Arrayit Corporation: Operating Segments
Table 132. Arrayit Corporation: Product Portfolio
Table 133. Arrayit Corporation: Net Sales
Table 134. Arrayit Corporation: Key Strategies
Table 135. BiomérieU.S.: Company Snapshot
Table 136. BiomérieU.S.: Operating Segments
Table 137. BiomérieU.S.: Product Portfolio
Table 138. BiomérieU.S.: Net Sales
Table 139. BiomérieU.S.: Key Strategies
Table 140. Bio-Rad Laboratories Inc.: Company Snapshot
Table 141. Bio-Rad Laboratories Inc.: Operating Segments
Table 142. Bio-Rad Laboratories Inc.: Product Portfolio
Table 143. Bio-Rad Laboratories Inc.: Net Sales
Table 144. Bio-Rad Laboratories Inc.: Key Strategies
Table 145. Danaher Corporation: Company Snapshot
Table 146. Danaher Corporation: Operating Segments
Table 147. Danaher Corporation: Product Portfolio
Table 148. Danaher Corporation: Net Sales
Table 149. Danaher Corporation: Key Strategies
Table 150. Diasorin Group: Company Snapshot
Table 151. Diasorin Group: Operating Segments
Table 152. Diasorin Group: Product Portfolio
Table 153. Diasorin Group: Net Sales
Table 154. Diasorin Group: Key Strategies
Table 155. GE Healthcare: Company Snapshot
Table 156. GE Healthcare: Operating Segments
Table 157. GE Healthcare: Product Portfolio
Table 158. GE Healthcare: Net Sales
Table 159. GE Healthcare: Key Strategies
Table 160. Illumina, Inc.: Company Snapshot
Table 161. Illumina, Inc.: Operating Segments
Table 162. Illumina, Inc.: Product Portfolio
Table 163. Illumina, Inc.: Net Sales
Table 164. Illumina, Inc.: Key Strategies
Table 165. Invitae Corporation: Company Snapshot
Table 166. Invitae Corporation: Operating Segments
Table 167. Invitae Corporation: Product Portfolio
Table 168. Invitae Corporation: Net Sales
Table 169. Invitae Corporation: Key Strategies
Table 170. Merck KGaA: Company Snapshot
Table 171. Merck KGaA: Operating Segments
Table 172. Merck KGaA: Product Portfolio
Table 173. Merck KGaA: Net Sales
Table 174. Merck KGaA: Key Strategies
Table 175. Microarray Inc.: Company Snapshot
Table 176. Microarray Inc.: Operating Segments
Table 177. Microarray Inc.: Product Portfolio
Table 178. Microarray Inc.: Net Sales
Table 179. Microarray Inc.: Key Strategies
Table 180. Nextgen Sciences: Company Snapshot
Table 181. Nextgen Sciences: Operating Segments
Table 182. Nextgen Sciences: Product Portfolio
Table 183. Nextgen Sciences: Net Sales
Table 184. Nextgen Sciences: Key Strategies
Table 185. Pathogendx, Inc.: Company Snapshot
Table 186. Pathogendx, Inc.: Operating Segments
Table 187. Pathogendx, Inc.: Product Portfolio
Table 188. Pathogendx, Inc.: Net Sales
Table 189. Pathogendx, Inc.: Key Strategies
Table 190. Perkinelmer Inc.: Company Snapshot
Table 191. Perkinelmer Inc.: Operating Segments
Table 192. Perkinelmer Inc.: Product Portfolio
Table 193. Perkinelmer Inc.: Net Sales
Table 194. Perkinelmer Inc.: Key Strategies
Table 195. Raybiotech Life, Inc.: Company Snapshot
Table 196. Raybiotech Life, Inc.: Operating Segments
Table 197. Raybiotech Life, Inc.: Product Portfolio
Table 198. Raybiotech Life, Inc.: Net Sales
Table 199. Raybiotech Life, Inc.: Key Strategies
Table 200. Schott Minifab: Company Snapshot
Table 201. Schott Minifab: Operating Segments
Table 202. Schott Minifab: Product Portfolio
Table 203. Schott Minifab: Net Sales
Table 204. Schott Minifab: Key Strategies
Table 205. Thermo Fisher Scientific, Inc.: Company Snapshot
Table 206. Thermo Fisher Scientific, Inc.: Operating Segments
Table 207. Thermo Fisher Scientific, Inc.: Product Portfolio
Table 208. Thermo Fisher Scientific, Inc.: Net Sales
Table 209. Thermo Fisher Scientific, Inc.: Key Strategies

List of Figures
Figure 1. Microarray Market Segmentation
Figure 2. Microarray Market, 2021-2031
Figure 3. Microarray Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Microarray Mark.:Drivers, Restraints and Opportunities
Figure 12. Microarray Market, By Product & Services, 2021(%)
Figure 13. Comparative Share Analysis of Consumable Microarray Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Instruments Microarray Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of Software and Services Microarray Market, 2021-2031(%)
Figure 16. Microarray Market, By by Type, 2021(%)
Figure 17. Comparative Share Analysis of Dna Microarray Microarray Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Protein Microarray Microarray Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Other Microarray Microarray Market, 2021-2031(%)
Figure 20. Microarray Market, By End-user, 2021(%)
Figure 21. Comparative Share Analysis of Research and Academic Institutes Microarray Market, 2021-2031(%)
Figure 22. Comparative Share Analysis of Pharmaceutical and Biotechnology Companies Microarray Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Diagnostic Laboratories Microarray Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Other End-users Microarray Market, 2021-2031(%)
Figure 25. Microarray Market by Region, 2021
Figure 26. U.S. Microarray Market, 2021-2031($Million)
Figure 27. Canada Microarray Market, 2021-2031($Million)
Figure 28. Mexico Microarray Market, 2021-2031($Million)
Figure 29. Germany Microarray Market, 2021-2031($Million)
Figure 30. France Microarray Market, 2021-2031($Million)
Figure 31. Uk Microarray Market, 2021-2031($Million)
Figure 32. Italy Microarray Market, 2021-2031($Million)
Figure 33. Spain Microarray Market, 2021-2031($Million)
Figure 34. Rest of Europe Microarray Market, 2021-2031($Million)
Figure 35. China Microarray Market, 2021-2031($Million)
Figure 36. Japan Microarray Market, 2021-2031($Million)
Figure 37. India Microarray Market, 2021-2031($Million)
Figure 38. Australia Microarray Market, 2021-2031($Million)
Figure 39. South Korea Microarray Market, 2021-2031($Million)
Figure 40. Rest of Asia-Pacific Microarray Market, 2021-2031($Million)
Figure 41. Brazil Microarray Market, 2021-2031($Million)
Figure 42. Saudi Arabia Microarray Market, 2021-2031($Million)
Figure 43. South Arabia Microarray Market, 2021-2031($Million)
Figure 44. Rest of LAMEA Microarray Market, 2021-2031($Million)
Figure 45. Top Winning Strategies, by Year
Figure 46. Top Winning Strategies, by Development
Figure 47. Top Winning Strategies, by Company
Figure 48. Product Mapping of Top 10 Players
Figure 49. Competitive Dashboard
Figure 50. Competitive Heatmap of Top 10 Key Players
Figure 51. Agilent Technologies, Inc.: Net Sales, ($Million)
Figure 52. Arrayit Corporatio.: Net Sales, ($Million)
Figure 53. Biomérieux S.: Net Sales, ($Million)
Figure 54. Bio-Rad Laboratories Inc.: Net Sales, ($Million)
Figure 55. Danaher Corporatio.: Net Sales, ($Million)
Figure 56. Diasorin Grou.: Net Sales, ($Million)
Figure 57. Ge Healthcar.: Net Sales, ($Million)
Figure 58. Illumina, Inc.: Net Sales, ($Million)
Figure 59. Invitae Corporatio.: Net Sales, ($Million)
Figure 60. Merck Kga.: Net Sales, ($Million)
Figure 61. Microarray Inc.: Net Sales, ($Million)
Figure 62. Nextgen Science.: Net Sales, ($Million)
Figure 63. Pathogendx, Inc.: Net Sales, ($Million)
Figure 64. Perkinelmer Inc.: Net Sales, ($Million)
Figure 65. Raybiotech Life, Inc.: Net Sales, ($Million)
Figure 66. Schott Minifa.: Net Sales, ($Million)
Figure 67. Thermo Fisher Scientific, In.: Net Sales, ($Million)

Executive Summary

According to the report, “Microarray Market," the microarray market was valued at $3.9 billion in 2021, and is estimated to reach $8.4 billion by 2031, growing at a CAGR of 7.8% from 2022 to 2031.

Microarray is one of the most recent advances being used for cancer research. Cancer has different stages based on its progression. The principle behind microarrays is that complementary sequences in the DNA bind to each other. As the unknown DNA molecules are cut into fragments by restriction endonucleases. The fluorescent markers are attached to these DNA fragments. These are then allowed to react with probes of the DNA chip. Then the target DNA fragments along with complementary sequences bind to the DNA probes. The remaining DNA fragments are washed away. The target DNA pieces can be identified by their fluorescence emission by passing a laser beam. A computer is used to record the pattern of fluorescence emission and DNA identification. This technique of employing DNA chips is very rapid, besides being sensitive and specific for the identification of several DNA fragments simultaneously. It provides assistance in pharmacological approach to treat various diseases including oral lesions. It also helps in analysing large amount of samples which have either been recorded previously or new samples. It provides a basis to genotype thousands of different loci at a time, which is useful for association and linkage studies to isolate chromosomal regions related to a particular disease. This array also can be used to locate chromosomal aberrations related to cancer, such as segments of allelic imbalance, which can be identified by loss of heterozygosity. Moreover, the microarrays can also be used to study the extent to which certain genes are turned on or off in cells and tissues. In this case, instead of isolating DNA from the samples, the RNA is isolated and measured. However, with the advent of new DNA sequencing technologies, some of the tests for which microarrays were used in the past now use DNA sequencing instead. But microarray tests still tend to be less expensive than sequencing, so they may be used for very large studies, as well as for some clinical tests.

The microarray market trends that aid the growth are increase in the application of microarray technique in the cancer research, increase in number of R&D activities for new and efficient products development and increase in healthcare expenditure have significantly contributed toward the growth of the market. Moreover, the development of new products with high potential of emerging economies are further expected to provide new opportunities for microarray market size expansion. However, lack of skilled professionals restrains the microarray market growth.

The impact of COVID-19 pandemic on the microarray industry was seen to be fairly positive owing to the increased application of microarray technique in the pandemic situation to detect the molecular tests and for mapping COVID-19 antibody. According to the article of National Institute of Health published in April 2021 named ‘CovidArray: A Microarray-Based Assay with High Sensitivity for the Detection of Sars-Cov-2 in Nasopharyngeal Swabs’, the microarray analysis was used to detect SARS-CoV-2 markers N1 and N2 in the nasopharyngeal swabs. The method was based on solid-phase hybridization of fluorescently-labeled amplicons upon RNA extraction and reverse transcription. This approach combined the physical-optical properties of the silicon substrate with the surface chemistry used to coat the substrate to obtain a diagnostic tool of great sensitivity. In addition, the advantages of using microarray technique with other techniques also triggered the demand for the microarray analysis.

By product & services, the market is classified into consumable, instruments, software and services. The consumable segment is projected to exhibit the highest CAGR of 8.1% during the forecast period due to its increase the usage of instruments, and expected launch of pipeline products.

By type, the market is classified into DNA microarray, protein microarray, other microarray. The protein microarray segment is projected to exhibit the highest CAGR of 8.5% during the forecast period due to surge in the demand of protein microarray analysis, and increase in the prevalence of diseases like cancer.

By end user, the market is classified into research and academic institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, other end users. The research and academic institutes segment is projected to exhibit the highest CAGR of 8.5% during the forecast period, owing to increase in prevalence of chronic diseases and rise in number of tobacco smokers which lead to disease like lung cancer.

By Region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). Asia-Pacific is expected to grow at the highest CAGR of 9.9%, owing to increase in number of cancers affected population and rise in awareness related to microarray analysis.

KEY FINDINGS OF STUDY

  • By product & services, the consumable segment accounted for major microarray market share in 2021.
  • By type, the protein microarray segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • By end user, the research and academic institutes segment is anticipated to grow with the highest CAGR of 8.5% throughout the forecast period.
  • By region, North America occupied major share of the global microarray industry in 2021.

Companies Mentioned

  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Diasorin Group
  • GE Healthcare
  • Illumina, Inc.
  • Invitae Corporation
  • Merck KGaA
  • Microarray Inc.
  • NextGen Sciences
  • PathogenDx, Inc.
  • PerkinElmer Inc.
  • RayBiotech Life, Inc.
  • Schott Minifab
  • Thermo Fisher Scientific, Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...